Ginkgo Bioworks Newsroom

Morgan Stanley Maintains Ginkgo Bioworks(DNA.US) With Hold Rating, Maintains Target Price $10

Futu NewsNov 19 22:31

Morgan Stanley Maintains Ginkgo Bioworks(DNA.US) With Hold Rating, Maintains Target Price $10

Futu NewsNov 19 16:36

BTIG Maintains Ginkgo Bioworks(DNA.US) With Sell Rating, Cuts Target Price to $6

Futu NewsNov 15 21:31

TD Cowen Maintains Ginkgo Bioworks(DNA.US) With Buy Rating, Maintains Target Price $10

Futu NewsNov 13 13:31

Positive Outlook for Ginkgo Bioworks: Strategic Developments and Financial Strength Bolster Buy Rating

TipRanksNov 13 12:48

Morgan Stanley Maintains Ginkgo Bioworks(DNA.US) With Hold Rating, Cuts Target Price to $10

Futu NewsOct 31 21:40

TD Cowen Maintains Ginkgo Bioworks(DNA.US) With Buy Rating, Maintains Target Price $10

Futu NewsSep 20 19:31

TD Cowen Initiates Ginkgo Bioworks(DNA.US) With Buy Rating, Announces Target Price $10

Futu NewsSep 20 08:32

Ginkgo Bioworks Holdings: A Buy Rating on Strategic AI Advancements and Market Expansion

TipRanksSep 20 08:17

BTIG Maintains Ginkgo Bioworks(DNA.US) With Sell Rating, Maintains Target Price $7

Futu NewsAug 27 18:31

BTIG Maintains Sell on Ginkgo Bioworks Holdings, Adjusts Price Target To $7 (1-40 Reverse Stock Split)

BenzingaAug 24 01:17

Ginkgo Bioworks Holdings Analyst Ratings

BenzingaAug 24 01:15

BTIG Maintains Ginkgo Bioworks(DNA.US) With Sell Rating, Cuts Target Price to $7

Futu NewsAug 23 19:31

Ginkgo Bioworks Holdings: Sell Rating Affirmed With Revised Valuation and Price Target

TipRanksAug 23 19:08

Morgan Stanley Maintains Ginkgo Bioworks(DNA.US) With Hold Rating, Maintains Target Price $40

Futu NewsAug 20 21:31

Analysts Offer Insights on Healthcare Companies: Ginkgo Bioworks Holdings (DNA) and LifeMD (LFMD)

TipRanksAug 20 20:52

Ginkgo Bioworks: Hold Rating Maintained Amid Revenue Uncertainty and Restructuring Challenges

TipRanksAug 12 21:19

Ginkgo Bioworks: Underperform Rating Due to Financial Strain and Uncertain Strategic Outcomes

TipRanksAug 9 20:34

Goldman Sachs Adjusts Price Target on Ginkgo Bioworks to $0.30 From $0.80, Maintains Sell Rating

MT NewswiresJul 9 22:35

Ginkgo Bioworks Holdings Analyst Ratings

BenzingaJul 9 22:32